APA (7th ed.) Citation

Claiborne, J. P., Tsai, H., Ghiaur, G., Smith, B. D., Gojo, I., DeZern, A. E., . . . Webster, J. A. (2026). Chemotherapy regimens with second generation tyrosine kinase inhibitors for BCR-ABL B-cell acute lymphoblastic leukemia: Comparative outcomes and role of allogeneic hematopoietic cell transplantation. Leukemia & Lymphoma, 67(5), 1066. https://doi.org/10.1080/10428194.2026.2628206

Chicago Style (17th ed.) Citation

Claiborne, John Preston, et al. "Chemotherapy Regimens with Second Generation Tyrosine Kinase Inhibitors for BCR-ABL B-cell Acute Lymphoblastic Leukemia: Comparative Outcomes and Role of Allogeneic Hematopoietic Cell Transplantation." Leukemia & Lymphoma 67, no. 5 (2026): 1066. https://doi.org/10.1080/10428194.2026.2628206.

MLA (9th ed.) Citation

Claiborne, John Preston, et al. "Chemotherapy Regimens with Second Generation Tyrosine Kinase Inhibitors for BCR-ABL B-cell Acute Lymphoblastic Leukemia: Comparative Outcomes and Role of Allogeneic Hematopoietic Cell Transplantation." Leukemia & Lymphoma, vol. 67, no. 5, 2026, p. 1066, https://doi.org/10.1080/10428194.2026.2628206.